Donepezil Hydrochloride 10 mg Tablet (Donepezil Hydrochloride Monohydrate)
Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Ilhwa Co., Ltd.
MFDS item code 202005095 · Approved 2020.07.15
This product's status changed to Expired on 2025.07.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of symptoms in Alzheimer's type dementia
This medicine is used in the treatment of Alzheimer's type dementia. It helps improve major symptoms such as memory decline and cognitive dysfunction, aiding patients in their daily lives. Additionally, it helps slow down the progression of dementia. It contributes to improving the patient's quality of life and supports overall mental function recovery. It is effective in alleviating symptoms when used safely.
As Donepezil Hydrochloride, administer 5 mg once daily before bedtime. If unusual dreams, nightmares, or insomnia occur, consider taking this medication in the morning. Donepezil's concentration reaches a steady state after 15 days of administration, and the frequency of adverse reactions may be affected by the rate of dose escalation, so administer 5 mg for 4-6 weeks. Assess clinical response during this period.
There is no experience using this medication in pediatric patients.
This medication should not be used by women who are allergic to specific ingredients or are pregnant or breastfeeding, and by patients with genetic lactose metabolism disorders. Patients with heart disease or a history of gastrointestinal diseases, asthmatics, or those with a history of specific allergies should be cautious when using this medication. This medication can cause various serious side effects such as slowed heart rate or arrhythmias, worsening of peptic ulcers, liver dysfunction, cerebrovascular issues, and motor disorders, so patients must consult a physician immediately if symptoms occur. Some patients may experience side effects such as nausea, vomiting, diarrhea, dizziness, insomnia, hallucinations, and aggressive behavior, which may require treatment discontinuation or dose adjustment. The effectiveness of this medication may vary depending on the type of dementia, so it should be used under the supervision of a specialist after an accurate diagnosis, and discontinuation should be considered if there is no therapeutic effect. Patients with poor heart health require regular cardiac monitoring, including ECG tests, and those with a history of gastrointestinal disease should carefully monitor for symptom exacerbation. This medication may affect driving or machine operation ability; caution is necessary at the start of treatment or when changing doses. Interactions with other medications may occur, especially when taken with drugs metabolized by the liver or those affecting the heart, so consult a doctor or pharmacist in such cases. It is generally advised that pregnant or breastfeeding women do not use this drug unless absolutely necessary and after consulting a specialist. The safety for children has not been established, so it should not be used in pediatric patients. In case of overdose, serious symptoms such as nausea, vomiting, bradycardia, and respiratory depression may occur, requiring immediate medical attention.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blistering, peeling skin, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory anomalies accompanied by cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure and at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the drug's effectiveness and safety.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.